Suchergebnisse - "Zarebinski, Maciej"

PubPharm (22)

1

The Role of Epicardial Adipose Tissue in Acute Coronary Syndromes, Post-Infarct Remodeling and Cardiac Regeneration

enthalten in: International journal of molecular sciences | 2024

von Krauz, K. | Kempiński, M. | Jańczak, P. | +4

2

Evaluation of Nitrosative/Oxidative Stress and Inflammation in Heart Failure with Preserved and Reduced Ejection Fraction

enthalten in: International journal of molecular sciences | 2023

von Momot, K. | Krauz, K. | Czarzasta, K. | +3

3

Multicenter registry of Impella-assisted high-risk percutaneous coronary interventions and cardiogenic shock in Poland (IMPELLA-PL)

enthalten in: Kardiologia polska | 2023

von Pietrasik, A. | Gąsecka, A. | Pawłowski, T. | +43

4

Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction-The REC-DUT-002 Trial

enthalten in: Journal of clinical medicine | 2022

von von Lewinski, D. | Benedikt, M. | Alber, H. | +12

5

A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI

enthalten in: International journal of cardiology | 2022

von Adlam, D. | Zarebinski, M. | Uren, N. | +26

6

Biochemical and clinical evaluation of endothelial injury after distal or traditional transradial access in percutaneous interventions

enthalten in: Kardiologia polska | 2022

von Momot, K. | Zarębiński, M. | Flis, K. | +3

CommentIn: Kardiol Pol. 2022;80(6):635-637. - PMID 35593104

7

Adiponectin promotes ischemic heart preconditioning- PRO and CON

enthalten in: Cytokine | 2020

von Niedziela, M. | Wojciechowska, M. | Zarębiński, M. | +2

8

Ticagrelor-Related Severe Dyspnoea : Mechanisms, Characteristic Features, Differential Diagnosis and Treatment

enthalten in: Clinical medicine insights. Case reports | 2020

von Krakowiak, A. | Kuleta, J. | Plech, I. | +4

9

Remote Ischemic Preconditioning in Renal Protection During Elective Percutaneous Coronary Intervention

enthalten in: Advances in experimental medicine and biology | 2018

von Wojciechowska, M. | Zarębiński, M. | Pawluczuk, P. | +6

10

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction : The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)

enthalten in: Circulation | 2016

von Michael Gibson, C. | Korjian, S. | Tricoci, P. | +14

CommentIn: Nat Rev Cardiol. 2017 Jan;14(1):6. - PMID 27883006